Clinical Trials Logo

Clinical Trial Summary

UPGRADE aims to see whether data from Pharmacogenomic Testing (PGx) can help physicians manage patient medication regimens and assess if the testing has an effect on reducing adverse drug reactions, hospitalizations and emergency department visits.

The way an individual processes a drug is in part determined by their genes, and there is known to be genetic variation between humans in the way drugs are metabolized. The study of the way genes affect a person's response to drugs is known as "Pharmacogenomics."


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort


Related Conditions & MeSH terms


NCT number NCT02081872
Study type Observational [Patient Registry]
Source Companion Dx Reference Lab, LLC
Contact Study Coordinator
Email upgrade@companiondxlab.com
Status Recruiting
Phase N/A
Start date April 2014
Completion date July 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01970709 - Diagnosing Adverse Drug Reactions Registry N/A
Recruiting NCT02095769 - Pharmacogenomic Testing Of the Elderly To Reduce Morbidity N/A